Phase 1 Fragile X Syndrome Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Completed

Phase 1

A Three Part, Randomized, Double-Blind, Placebo-Controlled, Phase I Study to evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GXV-001 in Healthy Volunteers

Fragile X SyndromeRett Syndrome

GEXVal AU PTY LTD88 enrolled1 locationACTRN12622000743763

Completed

Phase 1

Study of ZYN002 (cannabidiol gel) in 40 Healthy Volunteers

EpilepsyFragile X SyndromeOsteoarthritis

Zynerba Pharmaceuticals Pty. Ltd.40 enrolled2 locationsACTRN12618000183280